DNDefinate Nhamo

Definate Nhamo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Definate Nhamo has a total of 42 co-authors. Here are the top co-authors by number of shared publications:

  • Fern Terris-Prestholt

    The Joint United Nations Programme on HIV/AIDS (UNAIDS), Geneva, Switzerland

    3 shared publications
  • Chiedza Gavi

    Centre for Sexual Health, HIV/AIDS Research, Harare, Zimbabwe

    2 shared publications
  • Collin Mangenah

    Affiliations Centre for Sexual Health and HIV/AIDS Research (CeSHHAR), Harare, Zimbabwe, Department of International Public Health, Liverpool School of Tropical Medicine, Liverpool, United Kingdom

    2 shared publications
  • Dixon Chibanda

    Affiliation Department of psychiatry, University of Zimbabwe, Harare, Zimbabwe

    2 shared publications
  • Emily Gwavava

    Pangaea Zimbabwe AIDS Trust (PZAT), Harare, Zimbabwe

    2 shared publications
  • Frances M. Cowan

    Affiliations Centre for Sexual Health and HIV Research (CeSHHAR) Zimbabwe, Harare, Zimbabwe, Department of International Public Health, Liverpool School of Tropical Medicine (LSTM), Liverpool, United Kingdom

    2 shared publications

Latest Publications

  • Open Access

    A qualitative analysis of female sex workers’ lived experiences with adherence to Pre-exposure Prophylaxis (PrEP) in Zimbabwe

    by Definate Nhamo, Dixon Chibanda, Frances M. Cowan, Sinegugu E. Duma

    Background: Female sex workers (FSWs) are at an elevated risk of HIV infection with an eight-fold risk of HIV infection. In countries like Zimbabwe, FSWs have an HIV incidence of around 10.2%. With this elevated risk, the World Health Organization has prioritized Female sex workers (FSWS) for PrEP – an HIV prevention option taken as a daily pill during periods of risk but, FSWs continue to experience challenges with daily PrEP adherence due to daily dosing, related side effects, ARV stigma and low risk perception. This article presents the FSWs’ lived experiences with PrEP adherence in Zimbabwe. Methods: We purposively identified twenty FSWs and conducted individual interviews to understand FSW lived experiences with PrEP adherence. We applied Colaizzi’s seven steps of phenomenological analysis to develop the themes. Findings: Three main themes emerged, namely positive experiences with PrEP adherence, negative experiences with PrEP adherence and the meaning attached to PrEP adherence. The positive experiences theme had four sub-themes as, overcoming PrEP-related forgetfulness, overcoming mobility-related PrEP disruptions, overcoming COVID-19 pandemic-related PrEP experiences and overcoming PrEP-related side effects. The negative experiences theme had two sub-themes including, enduring GBV and stigma associated with PrEP use and, COVID-19-related disruptions to PrEP adherence. The third emerging them was on the meaning attached to PrEP adherence. This theme had one sub-theme on PrEP adherence as a survival strategy. Conclusion: Whilst FSWs reported both positive and negative experiences with PrEP adherence, it is important that FSWs used the meaning they attached to these experiences to take control of their lives and be more determined to use PrEP adherence for survival and protection from HIV. Based on these findings, we recommend close monitoring and support to promote adherence, minimize PrEP discontinuity and promote positive lived experiences with PrEP adherence.


  • Open Access

    Meta-analysis of Pregnancy Events in Biomedical HIV Prevention Trials in Sub-Saharan Africa: Implications for Gender Transformative Trials

    by Lara Lorenzetti, Nhi Dinh, Cason Whitcomb, Andres Martinez, Manju Chatani, Breanne Lievense, Definate Nhamo, Catherine Slack, Natalie Eley, Kathleen MacQueen

    Historically, pregnant and lactating populations (PLP) have been excluded or disenrolled from biomedical HIV prevention trials, despite being more likely to acquire HIV during pregnancy and the post-partum period. We conducted a meta-analysis of pregnancy events in biomedical HIV prevention trials in sub-Saharan Africa to support trialists moving toward more inclusive clinical and implementation studies. We searched peer-reviewed literature reporting pregnancy events and contraceptive requirements in HIV prevention trials between 2001 and 2022. We hypothesized four variables to explain variation: contraceptive requirements, study start year, study product, and sub-region. We fit a meta-analytic model to estimate individual effect sizes and sampling variances, then conducted sub-group analyses to assess moderating effects. We identified 38 references for inclusion, across which the proportion of pregnancy events was 8% (95% confidence interval [CI]: 6–10%) with high heterogeneity (I2 = 99%). Studies not requiring contraceptives (21%, 95%CI: 7–48%) reported a significantly higher proportion of pregnancy events than studies requiring two methods (5%, 95%CI: 2–10%). Studies launched between 2001 and 2007 (11%, 95%CI: 8–16%), microbicide gel trials (12%, 95%CI: 8–18%), and studies conducted in Western Africa (28%, 95%CI: 13–51%) reported higher proportions of pregnancy events than reference groups. Together, these variables have a moderating effect on pregnancy events (p < 0.0001), explaining 63% of heterogeneity in trials. Results describe how, over time, more stringent contraceptive requirements reduced pregnancy events, which ensured necessary statistical power but limited reproductive choice by participants. With the move toward continuing PLP on experimental products, trialists can utilize estimated pregnancy events reported here to inform strategies that accommodate participants’ changing fertility preferences.


  • Open Access

    Feasibility and economic costs of syphilis self-testing to expand test uptake among gay, bisexual and transgender men: results from a randomised controlled trial in Zimbabwe

    by Definate Nhamo, Collin Mangenah, Gwendoline Chapwanya, Takudzwa Mamvuto, Imelda Mahaka, Clarisse Sri-Pathmanathan, Rashida A Ferrand, Katharina Kranzer, Fern Terris-Prestholt, Michael Marks, et al.

    Background: Access to syphilis testing and treatment is frequently limited for men who have sex with men (MSM). A two-armed randomised controlled trial compared feasibility and costs of facility-based syphilis testing with self-testing among MSM in Zimbabwe. Methods: This randomised controlled trial was conducted in Harare, with participants randomised 1:1. Syphilis self-testing was offered in community-based settings. The primary outcome was the relative proportion of individuals taking up testing. Total incremental economic provider and user costs, and cost per client tested, diagnosed and treated were assessed using ingredients-based costing in 2020 US$. Results: A total of 100 men were enrolled. The two groups were similar in demographics. The mean age was 26 years. Overall, 58% (29/50) and 74% (37/50) of facility- and self-testing arm participants, respectively, completed syphilis testing. A total of 28% of facility arm participants had a reactive test, with 50% of them returning for confirmatory testing yielding 28% reactivity. In the self-testing arm, 67% returned for confirmatory testing, with a reactivity of 16%. Total provider costs were US$859 and US$736, and cost per test US$30 and US$15 for respective arms. Cost per reactive test was US$107 and US$123, and per client treated US$215 and US$184, respectively. The syphilis test kit was the largest cost component. Total user cost per client per visit was US$9. Conclusion: Syphilis self-testing may increase test uptake among MSM in Zimbabwe. However, some barriers limit uptake including lack of self-testing and poor service access. Bringing syphilis testing services to communities, simplifying service delivery and increasing self-testing access through community-based organisations are useful strategies to promote health-seeking behaviours among MSM.


  • Open Access

    Factors motivating female sex workers to initiate pre- exposure prophylaxis for HIV prevention in Zimbabwe

    by Definate Nhamo, Sinegugu E. Duma, Elizabeth B. Ojewole, Dixon Chibanda, Frances M. Cowan

    Background: Female sex workers (FSWs) have a 26 times greater chance of HIV infection compared to the women in the general population. The World Health Organization recommends pre-exposure prophylaxis (PrEP) for population groups with an HIV incidence of 3% or higher and FSWs in southern Africa fit this criteria. This study sought to understand factors that motivate FSWs to initiate PrEP, in Harare, Zimbabwe.Methods: We purposively selected and recruited 20 FSWs to participate in the study in-order to gain an in-depth understanding of factors that motivate FSWs to initiate PrEP in Harare, Zimbabwe. We identified FSW who had been initiated on PrEP at a specialized clinic providing comprehensive sexual reproductive health (SRH) services for sex workers including HIV prevention options. We used a descriptive phenomenological approach to collect and analyze the data. Data was analyzed using Colaizzi’s seven steps to analyze data.Findings: Two broad themes were identified as intrinsic and extrinsic motivators. The two broad themes each have several sub-themes. The sub-themes under intrinsic motivation were (i) Self- protection from HIV infection and (ii) condoms bursting. Six sub-themes were identified as external motivators for initiating PrEP, these included (i) occupational risk associated with sex work, (ii) increased chance of offering unprotected sex as a motivator to initiate PrEP, (iii) positive encouragement from others (iv) need to take care of the children and (v) prior participation in HIV prevention research studies and (vi) Gender Based Violence.Conclusions: Understanding the factors that motivate FSWs to initiate PrEP is critical in developing contextually appropriate strategies to promote PrEP initiation and adherence strategies within specific and eligible populations for receiving PrEP according to the WHO guidelines (2015).


  • Correction to: Efficiency in PrEP Delivery: Estimating the Annual Costs of Oral PrEP in Zimbabwe

    by Collin Mangenah, Definate Nhamo, Stephano Gudukeya, Emily Gwavava, Chiedza Gavi, Progress Chiwawa, Sandra Chidawanyika, Polite Muleya, Noah Taruberekera, Ngonidzashe Madidi, et al.


  • Open Access

    Efficiency in PrEP Delivery: Estimating the Annual Costs of Oral PrEP in Zimbabwe

    by Collin Mangenah, Definate Nhamo, Stephano Gudukeya, Emily Gwavava, Chiedza Gavi, Progress Chiwawa, Sandra Chidawanyika, Polite Muleya, Noah Taruberekera, Ngonidzashe Madidi, et al.

    Although oral PrEP is highly effective at preventing HIV acquisition, optimizing continuation among beneficiaries is challenging in many settings. We estimated the costs of delivering oral PrEP to populations at risk of HIV in seven clinics in Zimbabwe. Full annual economic costs of oral PrEP initiations and continuation visits were estimated from the providers’ perspective for a six-clinic NGO network and one government SGBV clinic in Zimbabwe (January–December 2018). Disaggregating costs of full initiation and incremental follow-up visits enabled modeling of the impact of duration of continuation on the cost per person-year ($pPY) on PrEP. 4677 people initiated oral PrEP, averaging 2.7 follow-up visits per person. Average cost per person initiated was $238 ($183–$302 across the NGO clinics; $86 in the government facility). The full cost per initiation visit, including central and direct costs, was $178, and the incremental cost per follow-up visit, capturing only additional resources used directly in the follow up visits, was $22. The average duration of continuation was 3.0 months, generating an average $pPY of $943, ranging from $839 among adolescent girls and young women to $1219 in men. Oral PrEP delivery costs varied substantially by scale of initiations and by duration of continuation and type of clinic. Extending the average oral PrEP continuation from 2.7 to 5 visits (about 6 months) would greatly improve service efficiency, cutting the $pPY by more than half.


  • Open Access

    P4-S2.03 Calculating BMI in HIV+ female adolescents: a case of shaping the health of adolescents in Zimbabwe: Shaz! plus project

    by D. Nhamo

    Background Body Mass Index (BMI) is a statistical measure which compares a person's weight and height. It is used to estimate a healthy body weight based on a person's height. This measure is pertinent to use in HIV positives since weight loss is used as a proxy measure for clinical progression of HIV disease in that more weight loss is associated with advancing disease and often precedes clinical symptoms. We sought to measure BMI among HIV+ female adolescents to see if this is the best tool to use in immune-compromised populations. Methods Data were pulled out from an ongoing RCT entitled SHAZ! Plus. (N=650). It enrols HIV +ive female adolescents who are out of school. Data were collected at baseline, 6, 12 and 18-month follow-up visits, with the project facilitating ongoing care, ART and support to those in need of it. BMI was calculated using Adolphe Quetelet BMI calculator of weight in kg over height in m2 (kg/m2). BMI prime 25 was also calculated and used to compare the BMI results. Sample of xx used. Results 64.5% of the cohort had BMIs falling within normal ranges 18.5 to 25. 33.8% had BMIs of 25. 64.5% had BMI prime that fell within normal ranges of 0.74 and 0.99. 33.8% had BMI prime of 1.00. The average BMI at baseline was 19.35 Weight ranged from 25 to 70 at baseline, average was 47.71. Conclusion Results call for the need to come up with an adjusted BMI index for female adolescents who are immuno-compromised to use as a standard measure for optimal health. BMI however has it's shortcomings since it does not measure the actual body fat. In resource poor settings, a simple tool like weight lost or gained over time might be a good indicator of clinical progression of HIV as opposed to validated tools like the BMI.